Keep in mind that Frequency Therapeutics is currently partnering with private practices to recruit, treat, and examine patients in the trial. These are practices with ENTs and Audiologists. So, there are private practices that support this direction for FX-322; it wouldn't surprise me if these are the first offices that provide the real product.
Audiologists do not have to be the ones who need to recruit people. That is the point. ENT practices like those that took on an agreement with Frequency Therapeutics can deal with this themselves. They don't need audiologists to do it for them.
Because it's shown to be most efficient at targeting the higher frequencies.
I'm curious if you know how many partnerships they have. I definitely agree with you that everything will be solid at the clinics that have partnerships. I've looked on their webpage and I don't see this information. I guess my source of confusion is over how bought in (or not) most clinics are...
The testing sites are mostly at very large referral ENT clinics that conduct multiple clinical trials. These are all reputable, influential clinics in their area. I have a feeling nearby clinics won't want to be left out, even though there will be a bit of a small lag.
I'd sure hope so. Do you have any idea when Frequency Therapeutics made the commitment for the Hearing Health Conference? If it was after they got the Phase 2 results, then we can be sure the data is going to be good.
Maybe this is a negligible thing, but I wonder if there's a data bias in the sense that people seeking out the big clinics are more likely to have an idiopathic cause. The inclusion criteria is basically stable sensorineural hearing loss that's either caused by noise exposure or another sudden cause. I guess the conclusion is dead hair cells either way, but it does make me wonder a bit... obviously, they are doing it the most reasonable way possible.
I was thinking the same, literally any day now but if I had to pick a day, Friday... with little rationale in that assumption.
Do you think anybody out there in the world is as on-the-edge-of-their-seats about this as those of us on this forum? I mean, who else would be?
I remember someone here saying that there is a massive French community that follows this thread and they use page-translation options to get all the latest info on FX-322. There's also quite an active community on the tinnitus, tinnitus research and hyperacusis subreddits. Beyond that, probably not much would be my guess.
Should we get a poll going?
Um, maybe more than we think.
You mean... like... curing baldness?
No, I don't think anybody is to the degree we are because we are the ones suffering. The Frequency Therapeutics team obviously have a vested interest for a successful drug, but ultimately if the drug fails it won't affect them like it will us.
Totally normal activity and has been going on for some time. This is part of the shares selling arrangement Lucchino has to avoid insider trading and it is pre-planned well out from the share selling date.
It's normal for executives to sell regularly in every company. They have lives which require cash flow/liquidity.
If he had sold because he already knew something about the results of the clinical trial(s), this would have been insider trading — which is highly illegal.
Was that Toby's prediction? Or is this some new doomsday date for numerologists?
No, I wrote on March 4th:
At the moment we are at minus 17 percent.
Member
